Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies.

Davis, Scott

Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies. [electronic resource] - Transplantation 04 2020 - 881-887 p. digital

Publication Type: Journal Article

1534-6080

10.1097/TP.0000000000002913 doi


Adult
Biomarkers--blood
Calcineurin Inhibitors--adverse effects
Drug Monitoring
Female
Graft Rejection--diagnosis
Graft Survival--drug effects
HLA Antigens--immunology
Humans
Immunosuppressive Agents--adverse effects
Isoantibodies--blood
Kidney Transplantation--adverse effects
Male
Middle Aged
Predictive Value of Tests
Retrospective Studies
Risk Assessment
Risk Factors
Tacrolimus--adverse effects
Time Factors
Treatment Outcome